The endothelium and endothelin: beyond vascular reactivity.
作者信息
Hassan Walid
出版信息
Ann Saudi Med. 2006 Sep-Oct;26(5):343-5. doi: 10.5144/0256-4947.2006.343.
Abstract
摘要
相似文献
1
The endothelium and endothelin: beyond vascular reactivity.内皮与内皮素：超越血管反应性
Ann Saudi Med. 2006 Sep-Oct;26(5):343-5. doi: 10.5144/0256-4947.2006.343.
2
Circulating levels of endothelin-1 in a homogenous Gulf Arab population with untreated essential hypertension.海湾阿拉伯同质人群中未经治疗的原发性高血压患者的内皮素-1循环水平。
Ann Saudi Med. 2006 Sep-Oct;26(5):364-9. doi: 10.5144/0256-4947.2006.364.
3
Nitrogen Oxide, Endothelin-1, and Serotonin in the Blood of Immature Spontaneously Hypertensive Rats.未成熟自发性高血压大鼠血液中的一氧化氮、内皮素-1和血清素
Bull Exp Biol Med. 2017 Jan;162(3):310-312. doi: 10.1007/s10517-017-3602-8. Epub 2017 Jan 14.
4
[Vascular reactivity in patients with arterial hypertension and metabolic disorders].[动脉高血压和代谢紊乱患者的血管反应性]
Klin Med (Mosk). 2008;86(9):28-31.
5
Activation of the endothelin system in insulin resistance.胰岛素抵抗中内皮素系统的激活。
QJM. 2001 Jun;94(6):321-6. doi: 10.1093/qjmed/94.6.321.
6
Diabetes, obesity and hypertension in urban and rural people of bedouin origin in the United Arab Emirates.阿拉伯联合酋长国贝都因族城乡居民中的糖尿病、肥胖症和高血压
J Trop Med Hyg. 1995 Dec;98(6):407-15.
7
PPARγ activation does not affect endothelin activity in non-diabetic patients with hypertension or hypercholesterolemia.在患有高血压或高胆固醇血症的非糖尿病患者中，过氧化物酶体增殖物激活受体γ（PPARγ）的激活并不影响内皮素活性。
Atherosclerosis. 2014 Jun;234(2):436-40. doi: 10.1016/j.atherosclerosis.2014.03.035. Epub 2014 Apr 5.
8
9
Exercise tolerance and hyperinsulinemia in cardiac syndrome X.心脏X综合征中的运动耐量与高胰岛素血症
Folia Med Cracov. 2004;45(1-2):13-23.
10
[Secretory function of the endothelium as a factor of vascular tone regulation in the norm and in cardiovascular pathology].[作为正常及心血管病理状态下血管张力调节因素的内皮分泌功能]
Ross Fiziol Zh Im I M Sechenova. 2001 Nov;87(11):1518-26.
引用本文的文献
1
Endothelial Reactive Oxygen Species: Key Players in Cardiovascular Health and Disease.内皮活性氧：心血管健康与疾病中的关键因素
Antioxid Redox Signal. 2025 Jun;42(16-18):905-932. doi: 10.1089/ars.2024.0706. Epub 2024 Sep 30.
2
HIF1A Knockout by Biallelic and Selection-Free CRISPR Gene Editing in Human Primary Endothelial Cells with Ribonucleoprotein Complexes.利用核糖核蛋白复合物在人原代内皮细胞中通过双等位基因和无选择的 CRISPR 基因编辑敲除 HIF1A。
Biomolecules. 2022 Dec 22;13(1):23. doi: 10.3390/biom13010023.
3
Tennis Courts in the Human Body: A Review of the Misleading Metaphor in Medical Literature.人体中的网球场：医学文献中误导性隐喻的综述
Cureus. 2022 Jan 21;14(1):e21474. doi: 10.7759/cureus.21474. eCollection 2022 Jan.
4
Long-term results (up to 18 years) of balloon angioplasty on systemic hypertension in adolescent and adult patients with coarctation of the aorta.青少年和成年主动脉缩窄患者系统性高血压球囊血管成形术的长期结果（长达18年）
Clin Cardiol. 2007 Feb;30(2):75-80. doi: 10.1002/clc.25.
本文引用的文献
1
Endothelial function: a barometer for cardiovascular risk?内皮功能：心血管风险的晴雨表？
Circulation. 2002 Aug 6;106(6):640-2. doi: 10.1161/01.cir.0000028581.07992.56.
2
Endogenously released endothelin-1 from human pulmonary artery smooth muscle promotes cellular proliferation: relevance to pathogenesis of pulmonary hypertension and vascular remodeling.人肺动脉平滑肌内源性释放的内皮素-1促进细胞增殖：与肺动脉高压发病机制及血管重塑的相关性
Am J Respir Cell Mol Biol. 2001 Jul;25(1):104-10. doi: 10.1165/ajrcmb.25.1.4331.
3
Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease.冠状动脉血管舒张功能障碍对冠心病不良长期预后的预后影响。
Circulation. 2000 Apr 25;101(16):1899-906. doi: 10.1161/01.cir.101.16.1899.
4
Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction.轻度冠状动脉疾病和内皮功能障碍患者的长期随访
Circulation. 2000 Mar 7;101(9):948-54. doi: 10.1161/01.cir.101.9.948.
5
Exercise--toning up the endothelium?运动——增强血管内皮功能？
N Engl J Med. 2000 Feb 17;342(7):503-5. doi: 10.1056/NEJM200002173420710.
6
Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension.维生素C通过恢复原发性高血压患者的一氧化氮活性来改善内皮依赖性血管舒张功能。
Circulation. 1998 Jun 9;97(22):2222-9. doi: 10.1161/01.cir.97.22.2222.
7
Reduced pulmonary clearance of endothelin-1 in pulmonary hypertension.肺动脉高压时内皮素-1的肺清除率降低。
Am Heart J. 1998 Apr;135(4):614-20. doi: 10.1016/s0002-8703(98)70276-5.
8
Prolonged reduction of high blood pressure with human nitric oxide synthase gene delivery.
Hypertension. 1997 Sep;30(3 Pt 1):307-13. doi: 10.1161/01.hyp.30.3.307.
9
Pulmonary vasoconstriction and hypertension in mice with targeted disruption of the endothelial nitric oxide synthase (NOS 3) gene.内皮型一氧化氮合酶（NOS 3）基因靶向破坏小鼠的肺血管收缩与高血压
Circ Res. 1997 Jul;81(1):34-41. doi: 10.1161/01.res.81.1.34.
10
Sustained hypertension induced by orally administered nitro-L-arginine.口服硝基-L-精氨酸诱导的持续性高血压。
Hypertension. 1993 Mar;21(3):359-63. doi: 10.1161/01.hyp.21.3.359.
Zotero 插件